MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer
- 6 August 2016
- journal article
- thoracic
- Published by Elsevier BV in Surgery
- Vol. 160 (6), 1591-1598
- https://doi.org/10.1016/j.surg.2016.06.025
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC-100-B-040-012)
This publication has 35 references indexed in Scilit:
- Down-Regulation of MiR-30c Promotes the Invasion of Non-Small Cell Lung Cancer by Targeting MTA1Cellular Physiology and Biochemistry, 2013
- Metastasis-Associated Protein 1/Nucleosome Remodeling and Histone Deacetylase Complex in CancerCancer Research, 2012
- MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor–Induced Cellular Proliferation and Downregulates the Oncogene BCL9Molecular Cancer Research, 2011
- Small RNAs Are Raising Big ExpectationsJNCI Journal of the National Cancer Institute, 2009
- The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implicationsClinical & Experimental Metastasis, 2008
- MicroRNA in Cancer PrognosisThe New England Journal of Medicine, 2008
- Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 InactivationCancer Research, 2007
- Metastasis Tumor Antigens, an Emerging Family of Multifaceted Master CoregulatorsPublished by Elsevier BV ,2007
- A microRNA expression signature of human solid tumors defines cancer gene targetsProceedings of the National Academy of Sciences of the United States of America, 2006
- Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-αHuman Pathology, 2004